MethodSense announced the launch of LuminLogic NextGen, a new AI-enabled quality and regulatory compliance platform that unifies eQMS, regulatory intelligence, submission readiness, and compliance management into a single solution. The platform delivers a fully configured, compliance-ready system in as little as one day rather than months.

At its core is an advanced intelligence layer grounded in 25+ years of MethodSense methodologies and decades of regulatory, quality, and product development expertise across the medical device industry. LuminLogic NextGen automatically adapts to the way each organization works, configuring around each unique business rather than redesigning the business around the platform.

Unlike legacy point solutions, LuminLogic NextGen unifies quality, regulatory, product, clinical, manufacturing, and commercialization into a single connected platform. Teams retain their autonomy while sharing information and workflows through a single source of truth, enabling continuous traceability, real-time visibility, AI-guided automation, and dramatically faster execution. For the first time, global regulatory compliance becomes a business accelerator rather than a cost of doing business.

"We have spent decades solving real-world problems that quietly delay development, submissions, and commercialization," said Rita King, CEO of MethodSense. "LuminLogic NextGen embeds that expertise into a connected platform, enabling organizations to execute with greater speed, organizational insight, and confidence across the entire product lifecycle."